Please choose your delivery country and your customer group
The COVID-19 pandemic has been a threat to readiness with its virulence and pathogenicity. Novel variants related to structural and genetic changes in the virus have been associated with differing disease severities and symptoms. Most studies looking at COVID-19 symptoms have focused on hospitalized inpatients and there is limited information on presenting symptoms in a young, healthy cohort such as active duty service members. With this limited data on symptoms, it is unknown how well screening tools work in a military population. This study aims to describe how well symptom screens for dyspnea, fever, and cough identify patients who tested positive for COVID-19 during the initial variant as compared to positive cases during times when there was predominantly the Delta variant.